ARTICLE | Company News
Actelion gets EU orphan product designation
February 21, 2001 8:00 AM UTC
The European Commission granted Orphan Medicinal Product designation to Actelion (SWX:ATLN) for its Tracleer bosentan dual endothelin receptor antagonist to treat pulmonary arterial hypertension. Last...